I am wondering if anybody else is interested in Rhone Poulenc. I became aware of this stock from John Dessauer's Investor's World. Anybody have any comments?In today's news: The U.S. Federal Trade Commission said it had approved the application of Novartis AG and CHIRON CORP to license certain gene therapy technologies to RHONE POULENC RORER INC. Licensing of the technology is required under an April 1997 consent order settling charges that the merger of Ciba-Geigy and Sandoz to form Novartis would reduce competition in the gene therapies for cancer and other diseases. "The licensing requirement is designed to restore competition for the development and commercialization of gene therapy treatments for cancer and (other diseases)," the FTC said in a statement.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat